GlassScriptPhysician profile
Jerry M Poche
NPI 1255407110
$880.09
in general payments reported to CMS, 2019-2025
17 companies · $86.39 in 2025
The $86.39 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $64.42 · 2022: $112 · 2023: $262 · 2024: $198 · 2025: $86.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $546.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $272.12 | 2022-2025 | |
| Abbott Laboratories | $83.90 | 2022-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $70.29 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $67.36 | 2023-2024 | Mounjaro, Zepbound |
| Allergan, INC. | $63.02 | 2019 | |
| Amgen INC. | $49.62 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.67 | 2022-2023 | Jardiance |
| Kowa Pharmaceuticals America, INC. | $32.90 | 2022-2023 | Livalo |
| Janssen Pharmaceuticals, INC | $31.69 | 2019 | |
| Pfizer INC. | $31.37 | 2020-2025 | |
| Novo Nordisk INC | $29.01 | 2024 | Rybelsus |
| Roche Diagnostics Corporation | $27.63 | 2020 | |
| Bausch Health US, LLC | $24.29 | 2020 | |
| Novartis Pharmaceuticals Corporation | $21.38 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.70 | 2024 | Airsupra |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $13.68 | 2023 | Quviviq |
| Astellas Pharma US INC | $13.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Poche listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.